(MENAFN- The Conversation) Professor Extraordinaire,
Professor Charles Wambebe has worked at Ahmadu Bello University, Zaria and Georgetown University, Washington DC. He also worked with WHO and served as the Pioneer DG/CEO of the National Institute for Pharmaceutical Research and Development, Abuja. Recipient of TWAS Prizes in Medical Sciences and Building Scientific Institutions in Africa. Served as Consultant to the AUC, ADB, ECA, WHO, UNDP. Pioneer Pro-Chancellor and Chairman, Bingham University, Nigeria. Fellow of the Nigerian Academy of Science, African Academy of Sciences, The World Academy of Sciences (TWAS), among others. Pioneered the R & D of Niprisan, for the management of sickle cell disorder. Developed phytomedicines for treatment of malaria, fungal infection, peptic ulcer and HIV. Published over 150 articles in international journals. Currently Professor ExtraOrdinaire at Tshwane University of Technology, Pretoria and Consultant to WHO on Traditional Medicine. He is also Honorary Professor of Pharmacology , Bingham University, Karu, Nigeria.
Expertise: R & D of medical products based on African Indigenous Medical Knowledge, food plants as well as edible insects. Targeted diseases include sickle cell disease, colon cancer, breast cancer, prostate cancer, diabetes, hypertension, HIV/AIDS, Covid-19. Professor Wambebe has expertise in clinical trials (protocol development and management). IPR and benefit sharing related to Traditional Medicine (patent, licensing, MoU), health research ethics, drug regulation including herbal medicines, training and mentoring of younger colleagues.
Experience
- –present Professor Extraordinaire, Tshwane University of Technology
MENAFN10052021000199003603ID1102059625
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.